Serological markers for melanoma
Authors:
- 1 August 2000
- journal article
- review article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 143 (2) , 256-268
Abstract
We present a review of current literature concerning the significance of serological markers in melanoma patients. Results for cytokines, cytokine receptors, cell adhesion molecules, S100 protein, me...Keywords
This publication has 82 references indexed in Scilit:
- S-100 protein in peripheral blood: A marker for melanoma metastasesJournal of the American Academy of Dermatology, 1999
- In situ expression patterns of melanoma-inhibiting activity (MIA) in melanomas and breast cancersThe Journal of Pathology, 1999
- RT-PCR for Tyrosinase-mRNA-Positive Cells in Peripheral Blood: Evaluation Strategy and Correlation with Known Prognostic Markers in 123 Melanoma PatientsJournal of Investigative Dermatology, 1998
- Peripheral Blood Tyrosinase Messenger RNA Detection and Survival in Malignant MelanomaJNCI: Journal of the National Cancer Institute, 1996
- Purification and analysis of growth regulating proteins secreted by a human melanoma cell lineMelanoma Research, 1992
- Neuron-specific enolase as a prognostic factor in metastatic malignant melanomaEuropean Journal of Cancer, 1992
- Regression analyses of prognostic factors in metastatic malignant melanomaEuropean Journal of Cancer and Clinical Oncology, 1989
- Plasma 5-S-cysteinyldopa differentiates patients with primary and metastatic melanoma from patients with dysplastic nevus syndrome and normal subjectsJournal of the American Academy of Dermatology, 1988
- S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system.Stroke, 1987
- A soluble protein characteristic of the nervous systemBiochemical and Biophysical Research Communications, 1965